<SEC-DOCUMENT>0001333493-20-000081.txt : 20200715
<SEC-HEADER>0001333493-20-000081.hdr.sgml : 20200715
<ACCEPTANCE-DATETIME>20200529140028
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001333493-20-000081
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20200529

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			eHealth, Inc.
		CENTRAL INDEX KEY:			0001333493
		STANDARD INDUSTRIAL CLASSIFICATION:	INSURANCE AGENTS BROKERS & SERVICES [6411]
		IRS NUMBER:				770470789
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		2625 AUGUSTINE DRIVE, SECOND FLOOR
		CITY:			SANTA CLARA
		STATE:			CA
		ZIP:			95054
		BUSINESS PHONE:		650-584-2700

	MAIL ADDRESS:	
		STREET 1:		2625 AUGUSTINE DRIVE, SECOND FLOOR
		CITY:			SANTA CLARA
		STATE:			CA
		ZIP:			95054
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i4ca06e83484247eabb757ca70840bd34_30"></div><div style="height:90pt;width:100%;"><div><img alt="ehealth_logo1.jpg" src="ehealth_logo1.jpg" style="height:71px;width:221px;"></div></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">May 29, 2020</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration: underline;">VIA EDGAR</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Securities and Exchange Commission</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Division of Corporation Finance</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Office of Healthcare &#38; Insurance</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Attn&#58; Mark Brunhofer and Sharon Blume</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">100 F Street, N.E.</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Washington, D.C. 20549</font></div><div><font><br></font></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:85.416%;"><tr><td style="width:1.0%;"></td><td style="width:4.191%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:91.809%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">RE&#58; </font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">eHealth, Inc.</font></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Form 10-K for the Fiscal Year Ended December 31, 2019</font></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Filed March 2, 2020</font></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">File No. 001-33071</font></td></tr></table></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Ladies and Gentlemen&#58;</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">eHealth, Inc. (the &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;us&#8221;) submits this letter in response to comments from the staff (the &#8220;Staff&#8221;) of the Securities and Exchange Commission (the &#8220;Commission&#8221;) received by letter dated May 6, 2020 relating to our Form 10-K for the fiscal year ended December 31, 2019 (File No. 000-33071) originally filed with the Commission on March 2, 2020 (the &#8220;2019 Form 10-K&#8221;).</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In this letter, the comments from the Staff have been recited in italicized, bold type, and each comment is followed by our response.</font></div><div><font><br></font></div><div id="i4ca06e83484247eabb757ca70840bd34_44"></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">Form 10-K for the Fiscal Year Ended December 31, 2019</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">Management's Discussion and Analysis of Financial Condition and Results of Operations</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">Member Acquisition, page 50</font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">1.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.67pt;">In the footnotes to the table on page 51 you describe how you calculate the variable cost per member presented in the table. You disclose in each instance that the denominator is a derived metric and describe how you calculated that divisor, but do not appear to disclose the rationale behind the computation. For each footnote in the table on page 51, please tell us why you calculate the divisor the way you do. In your response address each component, and tell us why some individual components themselves are divided by either three or four. In addition, tell us your consideration for disclosing this information in your filing or tell us where you disclose it.</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We disclose variable cost per approved member in our Form 10-K as a general measure of the effectiveness of our member acquisition investments for the two primary product groups that we sell. We provide one metric for our sale of Medicare Advantage, Medicare Supplement and Medicare Part D Prescription drug plans (collectively, &#8220;Medicare Plans&#8221;). We provide another metric for the sale of our individual and family plans and short-term health insurance (collectively, &#8220;IFP Plans&#8221;). Our marketing, advertising and customer care and enrollment expenses are broad investments to acquire Medicare Plan members and IFP Plan members. These investments are generally not targeted to certain specific products within our Medicare Plan business or within our IFP Plan business. Our products within our Medicare Plan and IFP Plan businesses have different constrained life time values (&#8220;LTVs&#8221;). We believe a way to measure the effectiveness with which we obtain new members with different LTVs is to allocate costs based on the value of the new members acquired. Thus, we allocate more costs to plans with higher LTV&#8217;s than we do to plans with a lower LTV. </font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">1</font></div></div></div><hr style="page-break-after:always"><div style="height:90pt;width:100%;"><div><font><br></font></div></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The numerator used to calculate each metric is the portion of the respective operating expenses for marketing and advertising and customer care and enrollment that is directly related to member acquisition for all Medicare Plans and for all IFP Plans, respectively. The denominator used to calculate each metric is based on a derived metric that represents the relative value of the new members acquired. For Medicare Plans, we call this derived metric Medicare Advantage (&#8220;MA&#8221;)-equivalent members, and for IFP Plans, we call this derived metric IFP-equivalent members. The calculations for MA-equivalent members and for IFP-equivalent members are based on the weighted number of approved members for Medicare Plans and IFP Plans during the period.</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Since we are not able to segregate costs by specific product within the two product groups as much of the costs are not targeted at specific products, we believe that computing variable cost per member by dividing marketing, advertising and customer care and enrollment costs by member, with members adjusted for the relative LTV of the product they are purchasing, is a proxy for determining the efficiency of our selling and marketing efforts. When we started reporting these metrics around the time of our adoption of ASC 606, the LTV of Medicare Part D prescription drug plan approved members was between one-third and one-fourth the LTV of approved members for Medicare Advantage and Medicare Supplement plans. Thus, we weigh a Medicare Part D member to be 25% of a Medicare Advantage member and a Medicare Supplement member to derive MA-equivalent members. The LTV of short term health insurance plan members was between one-half and one-third the LTV of major medical individual and family health insurance plans, so we weigh a short term insurance plan member to be 33% of a major medical individual and family health insurance plan member to derive IFP-equivalent members. We used the greater factor (four for Medicare Part D prescription drug plans and three for short term health insurance plans), which has the effect of increasing the cost per approved member. </font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In light of this comment, we will revise the disclosure in the footnotes to the metrics in future filings to more specifically indicate why we give more or less weight to certain members in the denominator of the calculation.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">Notes to Consolidated Financial Statements</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">Note 1 - Summary of Business and Significant Accounting Policies Commission Revenue, page 80</font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">2.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.67pt;">You disclose here that health insurance carriers are your customers yet you disclose or imply throughout your filing that the policyholders are your customers. In this regard, for example, on page 5 you indicate that you actively market various products to your &#8220;Medicare-eligible customers&#8221; and to your &#8220;individual and family and small business customers&#8221; and in your revenue recognition policy note on page 80 you discuss your customer care centers which appear to be accessed by policyholders. Please tell us how the identification of policyholders as customers is consistent with your determination for accounting purposes that the health insurance carriers are your customers. In your response, tell us how this apparent discrepancy is either meaningful to investors or, at a minimum, not confusing.</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Similar to other public companies who operate as health insurance agents, we define policyholders as customers in general discussions of our business because individuals who obtain coverage through a health insurance agent are commonly referred to as customers in the health insurance industry. We also routinely called applicants who applied for insurance through our platform, &#8220;customers&#8221; in our filings with the Commission and marketing materials prior to the adoption of ASC 606. While we use the term &#8220;customers&#8221; when discussing how we serve individuals who obtain insurance through our platform, health insurance carriers are our &#8220;customers&#8221; under ASC 606. </font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">ASC 606 defines a customer as &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">a party that has contracted with an entity to obtain goods or services that are an output of the entity&#8217;s ordinary activities in exchange for consideration</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8221;. We enter into written </font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">2</font></div></div></div><hr style="page-break-after:always"><div style="height:90pt;width:100%;"><div><font><br></font></div></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">agency contractual agreements with health insurance carriers outlining the payment terms and amount of commission that we earn on each policy sold. We do not have a contract with the applicant who purchases an insurance plan through our websites or call centers. Applicants are not obligated in any way to make payments to us, and we do not receive payments from them. Accordingly, we have concluded that our customers, as prescribed by ASC 606 and for purposes of revenue recognition, are the insurance carriers.</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our 2018 and 2019 Annual Reports on Form 10-K include Critical Accounting Policies and Notes to Consolidated Financial Statements disclosures that clearly state that the insurance carriers are our customers for purposes of ASC 606 and revenue recognition. This concept is described specifically in our 2019 Form 10-K on page 65 in the discussion of Critical Accounting Policies and Estimates, where we state, in part, that &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">our commission revenue results from approval of an application from health insurance carriers, which we define as our customers&#8230;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8221; and also on page 80 where we provide a similar disclosure in the Notes to Consolidated Financial Statements.</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">These disclosures are clear that under ASC 606 health insurance carriers are our only customers. We believe that investors are not confused by our use of the word &#8220;customer&#8221; to describe policyholders in general discussions regarding our business due to our specific disclosures relating to health insurance carriers being our customers under ASC 606 and because individuals who obtain coverage through a health insurance agent are commonly referred to as &#8220;customers&#8221; in the health insurance industry generally. However, in future filings, we will revise our disclosures in our filings with the Commission to make it even clearer that our customers are health insurance carriers from an accounting perspective under ASC 606. Specifically, we will indicate that while we refer to policyholders as our customers, insurance carriers are our customers under ASC 606.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">Note 2 - Revenue</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration: underline;">Revenue Recognition Based on Estimated Constrained LTV, page 85</font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">3.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.67pt;">On page 86 you disclose that you had sufficient additional information with respect to increases in LTVs and estimates of future cash collections related to prior period cohorts to recognize adjustment revenue related to these prior period cohorts in 2019. You then disclose that you recognized $50.8 million of adjustment revenue for Medicare Advantage plans during the fourth quarter of 2019. Please address the following&#58;</font></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:9pt;margin-bottom:6pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt;">Tell us what additional information surfaced in the fourth quarter of 2019 prompting recognition of additional revenue in that quarter. </font></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:9pt;margin-bottom:6pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt;">Tell us what enhancements you made to your Medicare Advantage LTV estimation models in the fourth quarter of 2019 that provide greater statistical certainty on expected cash collections. Tell us why you made these enhancements.</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As disclosed in our filings with the Commission, we organize approved health insurance applications by the month of the policy effective date and the type of plan in &#8220;cohorts&#8221;. We calculate revenue by estimating a LTV that is applied to each cohort and is based on three inputs&#58; (1) the rate at which approved members convert to paying members, (2) expected member attrition, and (3) the commission rates we expect to receive per paying member. These inputs into our LTV calculations are based on historical information and are computed for each product offering. Per ASC 606-10-32-5, in determining transaction price, we estimate commission revenue and apply a constraint in accordance with ASC 606-10-32-11, which states that </font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">an entity shall include in the transaction price some or all of an amount of variable consideration estimated in accordance with paragraph 606-10-32-8 only to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. Further, per ASC </font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">3</font></div></div></div><hr style="page-break-after:always"><div style="height:90pt;width:100%;"><div><font><br></font></div></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">606-10-32-14, a</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">t the end of each reporting period, an entity shall update the estimated transaction price (including updating its assessment of whether an estimate of variable consideration is constrained) to represent faithfully the circumstances present at the end of the reporting period and the changes in circumstances during the reporting period.</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In accordance with ASC 606-10-32-14, we regularly review and continue to enhance the predictive accuracy of our processes used to estimate LTVs as we obtain additional data and gain more information on how various factors impact member behavior, including the impact of such behavior on member attrition, and update our models and processes accordingly. Medicare Advantage policies can be active over a relatively long period of time. The collection period for some Medicare Advantage plan members is as long as 12 years, over which commissions are expected to be received. As a result, we update our estimates of LTV on a quarterly basis for all outstanding cohorts to assess whether revenue should be adjusted. Our estimates of LTV are subject to significant volatility and judgment, particularly during the first few years of the life of a cohort. Thus, increases or decreases to the LTV of a cohort in any given period may or may not be indicative of the need to revise the estimated transaction price of renewals from our existing members. Consistent with ASC 606-10-32-8 and 32-9, we also consider all available information and apply judgment in assessing whether the observable inputs will result in an increase or decrease to the LTV of a cohort.</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2019, we experienced significant fluctuations (both increases and decreases) in the LTVs of certain Medicare Advantage cohorts, particularly earlier period cohorts. There was also significant uncertainty as to the impact of the Medicare Advantage Open Enrollment Period (&#8220;OEP&#8221;) on member attrition and LTV, including whether prior member behavior would be indicative of future member attrition due to the increasing volume of our members. While LTVs were trending upward for earlier cohorts, we did not recognize the incremental adjustment revenue after considering factors outside of our influence and our experience in the business and industry per the accounting guidance in ASC 606-10-32-11 and 12. Prior to the fourth quarter of 2019, we were not able to conclude that it was probable that a significant reversal in the amount of cumulative revenue recognized would not occur.</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As background, the Centers for Medicare and Medicaid Services (&#8220;CMS&#8221;) revived the OEP for the first quarter of 2019. The OEP had not existed for many years before the first quarter of 2019. During the OEP in the first quarter of 2019, Medicare Advantage plan policyholders could change their plans or disenroll from them and return to the original Medicare program outside of the Medicare Annual Enrollment Period that occurs every year during the fourth quarter. The new opportunity to change or disenroll from Medicare Advantage plans during the first quarter of 2019 OEP had a direct impact on member attrition of cohorts that had enrolled prior to 2019. Attrition is an important input in calculating our Medicare Advantage plan LTVs. </font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our Medicare Advantage plan members grew at a rapid pace during 2019 and increased by approximately 130,000, or 88%, in 2019 compared to 2018, which required us to invest in better and more scalable tools to support such growth. During 2019, we began evaluating whether historical patterns of member behavior, particularly in light of the newly revived OEP, would be good indicators of future member behavior, particularly with respect to member attrition and its impact on estimated LTVs. With the OEP set to occur again in the first quarter of 2020, we believed there could be more changes to patterns related to member attrition of prior cohorts, since we had observed significant changes to member attrition after the OEP that occurred in the first quarter of 2019.</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Due to the expected occurrence of the OEP in the first quarter of 2020, the impact of the 2019 OEP on member attrition, and the significant increase in our Medicare Advantage plan enrollment, we engaged a valuation firm in 2019 to migrate our existing LTV model from Excel to a more powerful tool that was better equipped to handle the current and expected volumes of data from our increased membership levels and to incorporate more robust statistical capabilities to analyze and better estimate LTVs. The </font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">4</font></div></div></div><hr style="page-break-after:always"><div style="height:90pt;width:100%;"><div><font><br></font></div></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">enhanced model was built using Python and incorporated a generalized Kaplan&#8211;Meier approach, which is a non-parametric statistical model used to estimate member attrition from lifetime data and was completed in December 2019. By the quarter ended December 31, 2019, we also had the benefit of member attrition data that informed us about the impact of the re-adoption of the OEP in the first quarter of 2019, along with enhanced statistical tools, which allowed us to better estimate the impact of the 2020 OEP on member attrition of prior cohorts that was not available earlier. After we adopted the enhanced model in December 2019, we compared the LTVs resulting from the enhanced model to the LTVs from our original Excel model. We found the LTVs to be materially consistent for the prior period cohorts related to the adjustment revenue of $50.8 million, which gave us additional comfort that our estimates of LTVs and application of constraints in prior reporting periods were appropriate.</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As a result of the additional data and tools that were available during the fourth quarter of 2019 and after considering the guidance in ASC 606-10-32-11 and 12, we were confident that an increase in the LTVs of the affected cohorts would not result in a significant reversal of previously recognized revenue and recognized the incremental revenue on historical Medicare Advantage plans of $50.8 million.</font></div><div><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt;">Tell us what role, if any, Mr. Robert Hurley took in your revenue recognition practices, in general, and the enhancements identified in the preceding bullet, in particular.</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Mr. Robert Hurley was the President, Carrier &#38; Business Development of eHealth from January 2018 until March 1, 2020. He did not play any role in our revenue recognition practices or policy, including the enhancements to the Medicare Advantage LTV estimation model. While our accounting team spoke to Mr. Hurley from time to time about trends in the business because of his role as our President, Carrier &#38; Business Development and his relationship with our health insurance carrier customers, he was not asked about, and did not participate in discussions regarding revenue recognition. </font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Please direct your questions or comments to me at (650) 210-3162.</font></div><div><font><br></font></div><div style="text-align:right;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:42.948%;"><tr><td style="width:1.0%;"></td><td style="width:98.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Very truly yours,</font></td></tr><tr><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><font style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></font></font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#47;s&#47; Derek N. Yung</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derek N. Yung</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Principal Financial and Accounting Officer)</font></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:98.557%;"><tr><td style="width:1.0%;"></td><td style="width:2.552%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:93.448%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">cc&#58; </font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Scott Giesler, Esq., eHealth, Inc.</font></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patrick J. Schultheis, Esq. and Jeana S. Kim, Esq., Wilson Sonsini Goodrich &#38; Rosati, P.C.</font></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Richard Ramko, Partner, Ernst &#38; Young LLP</font></td></tr></table></div><div><font><br></font></div><div style="text-indent:-18pt;padding-left:18pt;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">5</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>ehealth_logo1.jpg
<TEXT>
begin 644 ehealth_logo1.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X1O 17AI9@  34T *@    @ "0 +  (
M   F   (A@$2  ,    !  $   $:  4    !   (K $;  4    !   (M $H
M  ,    !  (   $Q  (    F   (O $R  (    4   (XH=I  0    !   (
M]NH<  <   @,    >@  $2(<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M         %=I;F1O=W,@4&AO=&\@161I=&]R(#$P+C N,3 P,3$N,38S.#0
M $@    !    2     $  %=I;F1O=W,@4&AO=&\@161I=&]R(#$P+C N,3 P
M,3$N,38S.#0 ,C R,#HP,CHR." Q.3HS,CHT-P   J !  ,    !  $  .H<
M  <   @,   )%      <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M          8! P #     0 &   !&@ %     0  $7 !&P %     0  $7@!
M*  #     0 "   " 0 $     0  $8 " @ $     0  "C@         8
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MUM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$
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M<UO4HQJ4W3ELQM)JQ:AB6"&.),[$4*N?05)6L5960PI*8!10 4M "&B@ HI
M%% !10 44[ %% Q:*!'_V?_M "Q0:&]T;W-H;W @,RXP #A"24T#[0
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M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !0 /@# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]_**** "B
MC-% !1110 4449H **** "BC-&: "BBC- !1110 4444 %%&<T9Q0 449HS0
M 4444 %%&:,YH **** "BD+!>I%+GBBZ **** "BBC- #0"*".>E9?BCQ=I?
M@K1Y+[5]0L]-LX?OSW4RQ1K_ ,";BO+;S]OKX36FH?97\70&3UCM+AX_^^UC
MV_K7C8[/\MP$E'&8B%-OI*27YLSG5A'XW8]E)S1,VQ&/H,US7P_^*_AOXHV+
M7'A_6M.U>%.'^S3K(8SZ,.J_C72R\QM["NVEBJ6(H^UP\U)/JG=?@7&2>J/@
M7PI^W/\ $C4_VB]-\/S:Q;OI=QXDBTV2+[#"K-"UR(F7.-WW?XJ^^4^=?P!K
M\I_ 9_XS#T7_ +'.'_TN%?JQ'RB_2OQOP7SC'9A1QDL;5=3EJ-*[;LO*YYV6
MU)SC)S=]20<4CG:A^E+39/\ 5M]*_;I?"STCX-U/]M[XB0_M43^&8]6MUT>/
MQ4VEB'[%#N^SB[\K;G&[[G\5?>"/E![C-?EIJ_\ R?)>?]CV_P#Z<#7ZEICR
MQ].*_%/"'.,;CZV8K&574Y*EHW;=EKM<\W+ZDY.?,^HO6D;V%8?C7XD:%\-M
M+^V:]K&GZ3:EMH>[N%B5SZ#=U/L*\W7]O[X2R:A]F_X2V'S/[WV.Y\O_ +[\
MO;^M?J>.XARS!S5/%XB$)=G))_BSNE5A%VD['LVW(H85A^"OB#HWQ#TD7VBZ
MI8ZI:,<>;:W"S*/8[>A]JW!R:]*CB*=:"J49<T7U1HM5="ALTA:J.L:[9^'[
M"2ZO;JWL[>$;GDFD$:+]2>E>;ZS^VK\+=#N?+F\9:3(V<9MV:X7/^\@85Q8W
M.LOP;MBZ\*?K)+\R)5(1^)GJJG H)]?SK@/!'[3_ ( ^(]Y';Z1XJT6YNI#M
M2W:X$4S_ $1\,?RKT '<N0V1[5O@\QPN,A[3"5(S7>+37X#C.,M8L^(?VR_V
MR_'WPA_: U70M!U6VM=-MH8&CC:SCE8%XP3R1G[QKZZ^%7B"X\4?#30-2O&W
M7=_I]O/,P7;N=XU)..W)K\\_^"C?/[5^O?\ 7"U_]$)7WA\(?&.D:'\'/"<-
M]JEC:3?V-:/LFG2-B/)3G!-?BOA_Q!C*O$V;4<;7;ITYM14GHO>>U]CS<+6D
MZ]2,GHBQK'[1G@7P[KTVE7WBK0;348'\J6WEO(UE1_0KGK7;;\)QZ<5^5_[3
M-_!?_M:^(;F":&2"35U*R(ZLA'[OG=7Z8VGQ!T&Z2*&/6M*EFDPB(MU&69CT
M4#/6OI."?$!YSB\;AL3R05"7+&S^+62Z^G0VPN,]JYQ?V3XD\6_MS?$?3?VC
M-2\/PZQ;KI=OXDETZ.+[#"S"%;DQ*,XW?=_BK[ZBRT8/J.:_*?QTV?VPM9_[
M'*8_^3QK]+_'OQC\+_"32X[KQ%KFGZ3'(!L6>7:\G^ZGWF_X"*^9\*>),16J
MYG4S3$-PIU%9SEHE>7?8RP-:3<W-]3JQS2,V#7CVD?MX_"C6M06UA\76L<K'
M&ZXMIX(_^^W15_6O5-'UJS\1:9#>6-U;WEI.N^.:"421NI[AEX(K]CP&>9=C
M[K UX5+?RR3_ "9Z%.I"7P.Y\F?M(?&/7H;S^V4N+Z:TFO=6L;;3+:^N[1+.
M+3SY;2.UHZ.SR.KONE;RT1DX7YF;W']GWQ%JTC:MH.K7DNI2:/':W4%S-*DL
MWDW$9812NGRNZ,CC?_$I0_[35?'/[,5MXA\6W&K:1JBZ7)?K+]IMKBR2[M6>
M6/RI941BK([IM5]K;6VC*[OFKJ/A'\(['X1>')+&UFNKZXN9!+=WEP1YMRX1
M47.T!554145% 554"OC\FR?-J&<5,37?N/K=6>EO766J3244K(PITZBJ79V@
MXHH%%?HYU#<8%<I\8_BKIOP6^'>I>(M6?;:V*;MJ??F<D*B+_M,Q _&NKQBO
MC/\ X*U^-)(M,\(^'HY,0W$LU_,GJ4"I'_Z')^5?&\><0RR3(\1F,/BBM/5N
MR_%W.?%UO94G,\#U/6?'W[>'QE2W3==74I+0V^]DLM*@SRWLOW=S?>8[?O':
MM>Z:?_P205]'4W?C1EU!@,B/3]T,9QR.9 6^;O\ +_NUF?L$?'WX8? #X;7C
M:_KRV?B+5[EI+E5T^YD:.)/EB3<D97^^_P I_P"6E>]?\/$OA /^9KDQ_P!@
MN\_^-5^$\&\/<)X[!K,N)\9"KB*WO-2JI<M^FDD[][[;65CRL-1P\X<]>=W+
MS/B7XJ_!GQU^Q)\0;&^AOI+=I&8Z?JUB2L5QMZHZGHWW<HWRM_M5]W?LD_M&
M0_M'_"F/4I$2WUBQ/V74;=3P),9WJ/[CCYE_$?PUXY^UI^U3\)/CG\#]8T6V
M\1?:M46/[3IV[3+I2)X_F50S1@+N&4R3_'7FG_!+'QA-HWQLUC1]^VWU;2FD
M9/[\D3J4/_?,DOYT^'\PPG#?%L,KRC$JM@\0OA4U+DETVZW7S3UNT.C-4<2J
M=)WA(\F\(7L6G?M9Z7<7$T<-O#XMBDDD=U1$1;P,22W156OTQA^.G@I(U'_"
M6^'.!C_D)0__ !5?EEK_ (<NO&'QLOM(LA&;S5M;DLX YPOF2W#(-Q[+N(KU
MA?\ @F;\4F7/V71__ \?_$U\UX>\5YWE3Q<,JP+Q$74=VKZ>6B.? XBK!25.
M'-J??'_"^/!7_0V>&_\ P90__%4U_COX*VG_ (JSPWT_Z"4/_P 57P3_ ,.S
M?BE_SZZ/_P"!X_\ B:#_ ,$SOBD!_P >NC_^!X_^)K]*EXE<86_Y$T__ ";_
M ".[ZYB?^?9R-[>Q:E^VQ)<6\J3V]QXX:6.2-U9'1K[<""OWE*U^@_[3?Q]L
M/V<_A==:U<+'-?/_ */I]J6_X^9V'R@_[(^\Q_NK]*_-SX=^'+KPA^T;H>CW
MHC^V:3XD@LYPIROF172H=I_B7<#7N'_!57QI<:G\7-!T/?\ Z'I>F?:@N?\
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M3ZV<O\UZD8"I&->I"6[9\/\ CW_D\76O^QSG_P#2XU^K$?W%^@_E7Y3^/?\
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,(1A'EB4%%%%6!__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
